NIH: Scientists Discover New Molecular Pathway Shared by 2 Neurodegenerative Disorders
March 01, 2022
March 01, 2022
WASHINGTON, March 1 (TNSJou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:
Scientists from two independent research teams have discovered how the mislocalization of a protein, known as TDP-43, alters the genetic instructions for UNC13A, providing a possible therapeutic target that could also have implications in treating amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other forms of . . .
Scientists from two independent research teams have discovered how the mislocalization of a protein, known as TDP-43, alters the genetic instructions for UNC13A, providing a possible therapeutic target that could also have implications in treating amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other forms of . . .